In a record-breaking span of just 11 months, Moderna created, developed, manufactured, and got regulatory authorization for mRNA-1273, a two-dose covid vaccine that is one of the first two mRNA ...

Don't Miss: Today’s deals: $17.50 Apple AirTags, $50 off Madden NFL 25, $30 Crock-Pot Electric Lunch Box, more Produced by Moderna, the proposed vaccine (mRNA-1273) has been in trial for more ...

Advancements in mRNA vaccine technology are reshaping medicine, addressing challenges and expanding applications from ...

DRS of mRNA-1273 reveals the CCR4–NOT-mediated dynamics of its poly(A) tail in model cell lines. Credit: Nature (2025). DOI: 10.1038/s41586-025-08842-1 ...

4/5 and ancestral SARS-CoV-2 than mRNA-1273, with the highest geometric mean titer ratios observed in adults and in the subset of participants aged 65 years and older,” Moderna said. The new ...

and colleagues compared the prevalence of major structural birth defects by COVID-19 vaccination status and compared the prevalence by brand (Moderna mRNA-1273 versus Pfizer-BioNTech BNT162b2 ...

and mRNA-1273 (Moderna) vaccine, respectively. This contrasts with 10 extra cases of myocarditis per 1 million positive SARS-CoV-2 tests (figure 1).1 However, no confirmed cases of athletes with ...

Relative vaccine efficacy of a SARS-CoV-2 spike receptor-binding and N-terminal domain COVID-19 vaccine versus mRNA-1273: subgroup analyses - Oral Presentation Presenter: Spyros Chalkias Session ...